|
 |
TestimThis page contains recent news articles, when available, and an overview of Testim but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Testim (when available) Testosterone is an antineoplastic hormonal agent primarily used in the treatment of prostate cancer. Testosterone is a pure, nonsteroidal anti-androgen with affinity for androgen receptors (but not for progestogen, estrogen, or glucocorticoid receptors). Consequently, Testosterone blocks the action of androgens of adrenal and testicular origin which stimulate the growth of normal and malignant prostatic tissue. Prostate cancer is mostly androgen-dependent and can be treated with surgical or chemical castration. To date, antiandrogen monotherapy has not consistently been shown to be equivalent to castration. For topical testosterone replacement therapy in males with deficiency or absence of testosterone Mechanism Of Action: Testosterone competes with androgen for the binding of androgen receptors, consequently blocking the action of androgens of adrenal and testicular origin which stimulate the growth of normal and malignant prostatic tissue. News Articles on Testosterone Auxilium Pharmaceuticals to Present at the 28th Annual JP Morgan Healthcare ... - Dec 31, 2009 Auxilium markets Testim® 1%, a topical testosterone gel, for the treatment of hypogonadism through its approximately 190-person sales and marketing team. ... CNNMoney.com (press release) Auxilium Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and ... - Dec 29, 2009 Testim is the product marketed by Auxilium. For the manufacturing of Testim, the company depends on contract manufacturers. The company's product pipeline ... PRMinds (press release) EST, to discuss the top line results of the Peyronie's phase IIb study. The ... - Dec 16, 2009 Auxilium markets Testim® 1%, a topical testosterone gel, for the treatment of hypogonadism through its approximately 190-person sales and marketing team. ... PR-inside.com (press release) Endo Pharma Gets a Setback - Dec 11, 2009 Once launched, Fortesta and Aveed will compete with Auxilium Pharma's (AUXLt) Testim and Solvay Pharmaceuticals' AndroGel. Seeking Alpha (blog) Auxilium Pharmaceuticals Inc. Reports Operating Results (10-Q) - Nov 5, 2009 Auxilium markets Testim 1% a topical testosterone gel for the treatment of hypogonadism. Auxilium is developing additional Testim line extensions as well as ... GuruFocus.com Auxilium Pharma Q3 Loss Widens - Update - Oct 28, 2009 Testim, the company's hypogonadism treatment gel, sales increased 25.1% year-over-year to $40.2 million from $32.1 million. The company's revenue increase ... RTT News Low sex drive? Testosterone gel could help -- or not - Nov 2, 2009 ...the Web site for rival Testim asks. "You could have low testosterone. Testim may help. Ask your doctor." at available evidence regarding testosterone ... Pioneer Press Auxilium Pharmaceuticals to Present at the Lazard Capital Markets 6th Annual ... - Nov 11, 2009 Auxilium markets Testim® 1%, a topical testosterone gel, for the treatment of hypogonadism through its approximately 190-person sales and marketing team. ... CNNMoney.com (press release) CPEX losses ease in third quarter - Nov 5, 2009 Sales of the company's only approved drug have increased by 36 percent to $5 million, all from royalties from Testim, which delivers testosterone by ... New Hampshire Business Review Testosterone Is Sure Looking Virile - Oct 30, 2009 Earlier this year, Auxilium filed a petition with the FDA arguing that the agency shouldn't let a generic version of Testim onto the market without ... BusinessWeek Paladin Reports Record Third Quarter 2009 Financial Results - Nov 11, 2009 Pennsaid(R), Metadol(R), Trelstar(R), and Testim(R) which increased by 10% in the third quarter of 2009 compared to the corresponding period a year ago. ... Benzinga CPEX Pharmaceuticals Reports Third-Quarter 2009 Financial Results - Nov 4, 2009 The growth in revenues for the third quarter of 2009 was due to increased royalties on sales of Testim ® . This growth is due to a reported 17% increase in ... Earthtimes (press release) Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2009 Financial Results ... - Nov 1, 2009 Additionally, we achieved record Testim® revenues, completed an equity offering of $115.7 million and received what we believe is a positive response to our ... PR-CANADA.net (press release) Auxilium Pharmaceuticals, Inc. - SWOT Analysis - Oct 23, 2009 The company markets Testim, a testosterone replacement treatment for hypogonadism, primarily to urologists, endocrinologists, orthopedists and select ... PRMinds (press release) www.StockMarketingInc.com: Our members Profit!! (OTCBB: NTMI - NT Media Corp ... - Nov 2, 2009 Auxilium markets Testim(R) 1%, a topical testosterone gel, for the treatment of hypogonadism through its approximately 190-person sales and marketing team. ... TMC Net Endo to respond to FDA questions on Fortesta by mid-2010 - Oct 19, 2009 In the United States, Fortesta's competition, if ultimately approved, would include Testim, a testosterone gel which was developed and is marketed by ... MSN Money Ferring adquiere la autorización de comercialización de Testim Gel, para el ... - Nov 11, 2009 Testim es un tratamiento para el hipogonadismo masculino, trastorno que afecta a los varones a partir de los 50 años, con sÃntomas como disminución del ... acceso.com (Comunicado de prensa) Reazioni avverse per i bambini esposti casualmente al gel a base di Testosterone - Oct 28, 2009 ...della libido e comportamento aggressivo. Androgel e Testim sono impiegati negli uomini con scarsa produzione dell'ormone testosterone. ( Xagena Medicina ) XagenaSalute Paladin déclare des résultats financiers record pour le troisième trimestre 2009 - Nov 11, 2009 Trelstar(MD) et Testim(MD) dont les ventes ont augmenté de 10 % au troisième trimestre 2009 comparativement à la même période de l'année précédente. ... Maketwire (Communiqué de presse) TuÄŸladan yastık!.. - Oct 20, 2009 Gördüğünüz gibi bir hasırım, bir tuÄŸlam, bir de kırık testim var dünyalık olarak. BaÅŸkaca bir ÅŸeyim yoktur, diye arz etti. - Biliyorum evladım. ... Türkiye Auxilium signs promotional deal for Testim product - Apr 13, 2005 Auxilium Pharmaceuticals and Oscient Pharmaceuticals Corp. signed an agreement Wednesday to co-promote Auxilium's lead product, Testim, a treatment for ... Bizjournals.com Auxilium picks Canada firm to sell hormone drug. - Dec 12, 2006 Auxilium, in Malvern, said it will manufacture and supply Testim, a topical gel used to treat hypogonadism, to Paladin Labs Inc. of Montreal, Canada. ... Free with registration - Philadelphia Inquirer - AccessMyLibrary.com Patent protection for Auxilium's Testim extended to 2025 - Jan 22, 2008 Auxilium Pharmaceuticals Inc. said Tuesday that its Testim product used to restore and maintain normal testosterone levels now has patent protection through ... Bizjournals.com Auxilium Q2 loss narrows, set to resume Xiaflex trials - Jul 31, 2007 ..."Their revenues from Testim are doing very well this year... We saw a good quarter in terms of the numbers on Testim," Gershell said referring to the ... Reuters Auxilium Pharmaceuticals Receives Approval to Sell Testim(R) in Canada - May 23, 2006 MALVERN, Pa., May 23 /PRNewswire-FirstCall/ -- Auxilium Pharmaceuticals, Inc. , a specialty pharmaceutical company, today announced that Health Canada's ... RedOrbit … . Announces Distribution and License Agreement for Testim(R) in... - Dec 1, 2008 ..."Testim will be an excellent complement to our urology portfolio, where we already have ... Testim is currently approved for sale in 15 countries in Europe. ... Lifescience-online … Announces Top-Line Results From Phase IV Trial of Testim(R) in... - Jun 15, 2006 Patients in the Testim treatment group also experienced a statistically ... Study results showed that Testim appears to be safe when taken alongside oral ... UroToday International Journal Q3 2005 Auxilium Pharmaceuticals, Inc. Earnings Conference Call -... - Nov 8, 2005 I will discuss the performance of our lead product, TESTIM, ... In fact, TESTIM accounted for 87% of the total prescription growth in the gel market segment ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Auxilium leases facility, makes other moves - Sep 5, 2006 Auxilium Pharmaceuticals Inc. said Tuesday it has leased an existing biologics manufacturing facility for the production of Testim, its topical testosterone ... Bizjournals.com Should hypogonadal men who are suboptimally responsive to … - Nov 27, 2007 ...(2007) Efficacy of changing testosterone gel preparations (Androgel or Testim) among suboptimally responsive hypogonadal men. ... Nature.com Q1 2005 Oscient Pharmaceuticals Corporation Earnings Conference Call ... - May 2, 2005 The interpretation of results of clinical trials using Testim, the size of the ... For important information regarding the safety and use of Testim, ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Oscient Pharmaceuticals Announces Closing of $35.9 Million Private … - Apr 11, 2006 The Company is also promoting Auxilium Pharmaceuticals' TESTIM(R) 1% testosterone gel to primary care physicians in the US Oscient has a novel antibiotic ... Free with registration - Business Wire - AccessMyLibrary.com Q2 2007 Bentley Pharmaceuticals Earnings Conference Call - Final. - Aug 2, 2007 Secondly, we made important strides on the patent application to extend our protection of Testim which continues to enjoy strong sales. ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Auxilium Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year... - Feb 14, 2008 We achieved record revenues for Testim in 2007 and made tremendous progress ... Testim prescriptions grew by 35.2% in 2007 according to NPA data from IMS. ... marketwire.com Bentley Pharmaceuticals Reports Fiscal 2004 Revenues of $73.4 Million... - Mar 8, 2005 In January 2005, Testim was launched in Germany by Auxilium's partner, Ipsen. Testim has received marketing authorizations in two additional European ... Free with registration - Business Wire - AccessMyLibrary.com … Pharmaceuticals announces new strategic initiatives related to... - Oct 3, 2006 Specifically, the company leased an existing biologics manufacturing facility for the production of AA4500 and, to support the growth of Testim, ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Brand Names/Synonyms: Testim is also known by the following brand names and/or synonymsAA 2500; Andriol; Andro; Andro 100; Andro L.A. 200; Androderm; Androgel; Android 10; Android 25; Android 5; Androlin; Andronaq; Andronate 100; Andronate 200; Andropatch; Andropository 200; Andrusol; Andryl 200; Beta Testosterone; CCRIS 574; CDB 111C; COL 1621; CP 601B; Cristerona T; Cristerone T; Dea No. 4000; Delatest; Delatestryl; Depo-Testosterone; Depo-Testosterone Cypionate; Depotest; Dofsol; Everone 200; Geno-Cristaux Gremy; HSDB 3398; Homosteron; Homosterone; Libigel; Malerone; Malestrone; Malogen in Oil; Malogen, Aquaspension Injection; Mertestate; Metandren; Methyltestosterone; NSC 9700; Neo-Hombreol F; Neo-Testis; Neotestis; Oreton; Oreton F; Oreton Methyl; Oreton-F; Orquisteron; Perandren; Percutacrine Androgenique; Primotest; Primoteston; Relibra; Scheinpharm Testone-Cyp; Striant; Sustanon; Sustanone; Sustason 250; Synandrol F; T-Cypionate; TES; Teslen; Testamone 100; Testandrone; Testaqua; Testex; Testiculosterone; Testim; Testobase; Testoderm; Testoderm Tts; Testogel; Testoject-50; Testolin; Testopel Pellets; Testopropon; Testosteroid; Testosteron; Testosterona [Inn-Spanish]; Testosterone; Testosterone Cypionate; Testosterone Enanthate; Testosterone Hydrate; Testosterone Propionate; Testosterone [Ban:Inn]; Testosterone and Its Esters; Testosteronum [Inn-Latin]; Testostosterone; Testoviron; Testoviron Schering; Testoviron T; Testred; Testred Cypionate 200; Testrin-P.A; Testro Aq; Testrone; Testryl; Trans-Testosterone; Virilon; Virilon Im; Virormone; Virosterone Drug Category: Testim is categorized under the following by the FDA: Antineoplastic Agents; Anabolic Agents; Androgens; ATC:G03BA02; ATC:G03BA03; ATC:G03EK01 Dosage Forms: CAPSULE; GEL; LIQUID; PATCH; SOLUTION; SUSPENSION Absorption: Approximately 10% of the testosterone dose applied on the skin surface from AndroGel® is absorbed into systemic circulation Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: 17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |
